- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 847821, 8 pages
Effects of SCH-23390 in Combination with a Low Dose of 17β-Estradiol on Anxiety-Like Behavior in Ovariectomized Rats
Laboratory of Neuroendocrinology, I. P. Pavlov Institute of Physiology of the Russian Academy of Science, 6 Emb. Makarova, Saint Petersburg 199034, Russia
Received 25 April 2013; Revised 29 December 2013; Accepted 19 January 2014; Published 23 February 2014
Academic Editor: George Perry
Copyright © 2014 Julia Fedotova. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. P. de la Mora, A. Gallegos-Cari, Y. Arizmendi-García, D. Marcellino, and K. Fuxe, “Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis,” Progress in Neurobiology, vol. 90, no. 2, pp. 198–216, 2010.
- M. R. Diaz, A. M. Chappell, D. T. Christian, N. J. Anderson, and B. A. McCool, “Dopamine D3-like receptors modulate anxiety-like behavior and regulate gabaergic transmission in the rat lateral/basolateral amygdala,” Neuropsychopharmacology, vol. 36, no. 5, pp. 1090–1103, 2011.
- T. Kienast, A. R. Hariri, F. Schlagenhauf et al., “Dopamine in amygdala gates limbic processing of aversive stimuli in humans,” Nature Neuroscience, vol. 11, no. 12, pp. 1381–1382, 2008.
- J. E. LeDoux, “Emotion circuits in the brain,” Annual Review of Neuroscience, vol. 23, pp. 155–184, 2000.
- M. Savasta, A. Dubois, and B. Scatton, “Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390,” Brain Research, vol. 375, no. 2, pp. 291–301, 1986.
- K. L. Nowend, M. Arizzi, B. B. Carlson, and J. D. Salamone, “D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption,” Pharmacology Biochemistry and Behavior, vol. 69, no. 3-4, pp. 373–382, 2001.
- J. T. Trevitt, B. B. Carlson, K. Nowend, and J. D. Salamone, “Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat,” Psychopharmacology, vol. 156, no. 1, pp. 32–41, 2001.
- C. E. Macedo, R. C. R. Martinez, L. Albrechet-Souza, V. A. Molina, and M. L. Brandão, “5-HT2 and D1-mechanisms of the basolateral nucleus of the amygdala enhance conditioned fear and impair unconditioned fear,” Behavioural Brain Research, vol. 177, no. 1, pp. 100–108, 2007.
- F. A. Guarraci, R. J. Frohardt, and B. S. Kapp, “Amygdaloid D1 dopamine receptor involvement in Pavlovian fear conditioning,” Brain Research, vol. 827, no. 1-2, pp. 28–40, 1999.
- S. Cabib and S. Puglisi-Allegra, “Opposite responses of mesolimbic dopamine system to controllable and uncontrollable aversive experiences,” Journal of Neuroscience, vol. 14, no. 5, pp. 3333–3340, 1994.
- A. J. Dunn, “Stress-related activation of cerebral dopaminergic systems,” Annals of the New York Academy of Sciences, vol. 537, pp. 188–205, 1988.
- B. B. Sherwin, “Estrogen and cognitive aging in women,” Neuroscience, vol. 138, no. 3, pp. 1021–1026, 2006.
- M. J. Zuluaga, D. Agrati, M. Pereira, N. Uriarte, A. Fernández-Guasti, and A. Ferreira, “Experimental anxiety in the black and white model in cycling, pregnant and lactating rats,” Physiology and Behavior, vol. 84, no. 2, pp. 279–286, 2005.
- J. D. Higley, S. J. Suomi, and M. Linnoila, “CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys,” Psychopharmacology, vol. 103, no. 4, pp. 551–556, 1991.
- K. Matthews, J. W. Dalley, C. Matthews, et al., “Periodic maternal separation of neonatal rats produces regionand gender-specific effects on biogenic amine content in postmortem adult brain,” Synapse, vol. 40, pp. 1–10, 2001.
- U. Finckh, H. Rommelspacher, S. Kuhn et al., “Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism,” Pharmacogenetics, vol. 7, no. 4, pp. 271–281, 1997.
- C. Nath, R. C. Saxena, and M. B. Gupta, “Effect of dopamine agonists and antagonists on the lorazepam withdrawal syndrome in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 27, no. 3, pp. 167–171, 2000.
- J. M. Finlay, M. J. Zigmond, and E. D. Abercrombie, “Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam,” Neuroscience, vol. 64, no. 3, pp. 619–628, 1995.
- A. Imperato, S. Puglisi-Allegra, A. Zocchi, M. G. Scrocco, P. Casolini, and L. Angelucci, “Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam,” European Journal of Pharmacology, vol. 175, no. 2, pp. 211–214, 1990.
- B. Gao and M. G. Cutler, “Effects of quinpirole on the behaviour shown by mice in the light-dark box and during social interactions,” Neuropharmacology, vol. 32, no. 1, pp. 93–100, 1993.
- A. A. Walf and C. A. Frye, “A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior,” Neuropsychopharmacology, vol. 31, no. 6, pp. 1097–1111, 2006.
- M. R. Zarrindast, N. Eslahi, A. Rezayof, P. Rostami, and M. Zahmatkesh, “Modulation of ventral tegmental area dopamine receptors inhibit nicotine-induced anxiogenic-like behavior in the central amygdala,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 5, pp. 11–17, 2013.
- C. Leranth, R. H. Roth, J. D. Elswoth, F. Naftolin, T. L. Horvath, and J. Redmond D.E., “Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory,” Journal of Neuroscience, vol. 20, no. 23, pp. 8604–8609, 2000.
- J. B. Becker, “Direct effect of 17β-estradiol on striatum: sex differences in dopamine release,” Synapse, vol. 5, no. 2, pp. 157–164, 1990.
- J. B. Becker, “Gender differences in dopaminergic function in striatum and nucleus accumbens,” Pharmacology Biochemistry and Behavior, vol. 64, no. 4, pp. 803–812, 1999.
- S. K. Mani, J. D. Blaustein, and B. W. O'Malley, “Progesterone receptor function from a behavioral perspective,” Hormones and Behavior, vol. 31, no. 3, pp. 244–255, 1997.
- A. Markou, T. Duka, and G. M. Prelevic, “Estrogens and brain function,” Hormones, vol. 4, no. 1, pp. 9–17, 2005.
- B. McEwen, “Estrogen actions throughout the brain,” Recent Progress in Hormone Research, vol. 57, pp. 357–384, 2002.
- T. Di Paolo, P. Falardeau, and M. Morissette, “Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle,” Life Sciences, vol. 43, no. 8, pp. 665–672, 1988.
- M. Morissette and T. Di Paolo, “Sex and estrous cycle variations of rat striatal dopamine uptake sites,” Neuroendocrinology, vol. 58, no. 1, pp. 16–22, 1993.
- M. Bourin and M. Hascoët, “The mouse light/dark box test,” European Journal of Pharmacology, vol. 463, no. 1–3, pp. 55–65, 2003.
- J. Fedotova and N. Ordyan, “Involvement of D1 receptors in depression-like behavior of ovariectomized rats,” Acta Physiologica Hungarica, vol. 98, no. 2, pp. 165–176, 2011.
- E. Estrada-Camarena, A. Fernández-Guasti, and C. López-Rubalcava, “Antidepressant-like effect of different estrogenic compounds in the forced swimming test,” Neuropsychopharmacology, vol. 28, no. 5, pp. 830–838, 2003.
- E. Estrada-Camarena, A. Fernández-Guasti, and C. López-Rubalcava, “Interaction between estrogens and antidepressants in the forced swimming test in rats,” Psychopharmacology, vol. 173, no. 1, pp. 139–145, 2004.
- V. Harsh, S. Meltzer-Brody, D. R. Rubinow, and P. J. Schmidt, “Reproductive aging, sex steroids, and mood disorders,” Harvard Review of Psychiatry, vol. 17, no. 2, pp. 87–102, 2009.
- W. Zhou, K. A. Cunningham, and M. L. Thomas, “Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats,” Molecular Brain Research, vol. 100, no. 1-2, pp. 75–83, 2002.
- B. Costall, C. A. Hendrie, M. E. Kelly, and R. J. Naylor, “Actions of sulpiride and tiapride in a simple model of anxiety in mice,” Neuropharmacology, vol. 26, no. 2-3, pp. 195–200, 1987.
- E. M. Pich and R. Samanin, “Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine,” Psychopharmacology, vol. 89, no. 1, pp. 125–130, 1986.
- A. M. Becerra Garcia, R. Martinez, M. L. Brandão, and S. Morato, “Effects of apomorphine on rat behavior in the elevated plus-maze,” Physiology and Behavior, vol. 85, no. 4, pp. 440–447, 2005.
- P. Simon, C. Panissaud, and J. Costentin, “Anxiogenic-like effects induced by stimulation of dopamine receptors,” Pharmacology Biochemistry and Behavior, vol. 45, no. 3, pp. 685–690, 1993.
- J. D. Blaustein, “Minireview: neuronal steroid Hormone receptors: they're not just for hormones anymore,” Endocrinology, vol. 145, no. 3, pp. 1075–1081, 2004.
- A. N. Talalaenko, I. A. Abramets, Y. V. Stakhovskii, A. A. Shekhovtsov, A. V. Chernikov, and S. L. Shevchenko, “The role of dopaminergic mechanisms of the brain in various models of anxious states,” Neuroscience and Behavioral Physiology, vol. 24, no. 3, pp. 284–288, 1994.
- M. Febo, L. A. González-Rodríguez, D. E. Capó-Ramos, N. Y. González-Segarra, and A. C. Segarra, “Estrogen-dependent alterations in D2/D3-induced G protein activation in cocaine-sensitized female rats,” Journal of Neurochemistry, vol. 86, no. 2, pp. 405–412, 2003.
- D. E. Dluzen, “Unconventional effects of estrogen uncovered,” Trends in Pharmacological Sciences, vol. 26, no. 10, pp. 485–487, 2005.
- T. Di Paolo, A. Dupont, and M. Daigle, “Effect of chronic estradiol treatment on dopamine concentrations in discrete brain nuclei of hypophysectomized female rats,” Neuroscience Letters, vol. 32, no. 3, pp. 295–300, 1982.
- T. Di Paolo, P. Poyet, and F. Labrie, “Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors,” European Journal of Pharmacology, vol. 73, no. 1, pp. 105–106, 1981.
- R. E. Hruska and E. K. Silbergeld, “Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model,” Science, vol. 208, no. 4451, pp. 1466–1468, 1980.
- R. E. Hruska, “Elevation of striatal dopamine receptors by estrogen: dose and time studies,” Journal of Neurochemistry, vol. 47, no. 6, pp. 1908–1915, 1986.
- P. G. Mermelstein, J. B. Backer, and D. J. Surmeier, “Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor,” Journal of Neuroscience, vol. 16, no. 2, pp. 595–604, 1996.
- T. L. Thompson and R. L. Moss, “Modulation of mesolimbic dopaminergic activity over the rat estrous cycle,” Neuroscience Letters, vol. 229, no. 3, pp. 145–148, 1997.